Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 6286 AL 6300

Practical Assessment of Neuropsychiatric Symptoms: Updated Reliability, Validity, and Cutoffs for the Neuropsychiatric Inventory Questionnaire

González DA, Finley JA, Patel SES, Soble JR.

Am J Geriatr Psychiatry. 2025 May;33(5):524-534. doi: 10.1016/j.jagp.2024.10.014. Epub 2024 Oct 28.

Structural Brain Differences in the Alzheimer's Disease Continuum: Insights Into the Heterogeneity From a Large Multisite Neuroimaging Consortium

Evans TE, Vilor-Tejedor N, Operto G, Falcon C, Hofman A, Ibáñez A, Seshadari S, Tan LCS, Weiner M, Alladi S, Anazodo U, Gispert JD; Alzheimer’s Disease Neuroimaging Initiative; Australian Imaging Biomarkers and Lifestyle flagship study of ageing; Adams HHH.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2025 Oct;10(10):1025-1036. doi: 10.1016/j.bpsc.2024.07.019. Epub 2024 Jul 30.

The complementary role of egocentric and allocentric spatial navigation tasks for the diagnosis of Alzheimer's disease: A diagnostic meta-analysis

Serino S, Stramba-Badiale C, Magni G, Castegnaro A, Riva G, Tuena C.

Neurosci Biobehav Rev. 2025 Nov;178:106379. doi: 10.1016/j.neubiorev.2025.106379. Epub 2025 Sep 20.

Emotion regulation strategies to improve outcomes in family caregivers of people with Alzheimer's disease and related dementias: A systematic review

Dicker EE, Jones JS, Kunik ME, Denny BT.

J Health Psychol. 2025 Dec;30(14):4564-4580. doi: 10.1177/13591053251354882. Epub 2025 Aug 17.

Cerebral blood flow alterations in the precuneus of Alzheimer's disease using arterial spin labeling: A systematic review and meta-analysis

Ghaderi S, Mohammadi S, Fatehi F.

Brain Res Bull. 2025 Sep;229:111444. doi: 10.1016/j.brainresbull.2025.111444. Epub 2025 Jun 28.

Psychometric properties of the NIH Toolbox Cognition Battery composites in older adults at risk for Alzheimer's disease and related dementias: A systematic review

Thomas AB, Matthews AL, Brooks O, Winquist A, Nelson LA, Arias-Fontenot R, Buchwald D, Casaletto KB, Weintraub S, Heaton RK, French BF, Suchy-Dicey A, Barbosa-Leiker C.

Alzheimers Dement. 2025 Oct;21(10):e70673. doi: 10.1002/alz.70673.

Severe symptomatic amyloid-related imaging abnormalities in Alzheimer's disease: Two case reports and systematic review of reported cases

Villarejo Galende A, González-Sánchez M, Hilario A, Llamas-Velasco S, Morenas-Rodríguez E, Muñoz-García MI, Ramos-González A, Pérez-Martínez DA, Blanco-Palmero VA.

J Alzheimers Dis. 2026 Feb;109(3):1099-1116. doi: 10.1177/13872877251404505. Epub 2025 Dec 12.

Practical brain MRI guidelines for anti-Aβ antibody treatment in early symptomatic Alzheimer's disease

Kakeda S, Miki Y, Kudo K, Mori H, Tokumaru AM, Abe O, Aoki S; Working Group for Brain MRI Guidelines for Anti-Aβ Antibody Treatment from The Japan Radiological Society, The Japanese Society for Neuroradiology, and The Japanese Society for Magnetic Resonance in Medicine.

Jpn J Radiol. 2025 Aug;43(8):1231-1238. doi: 10.1007/s11604-025-01773-x. Epub 2025 Apr 23.

Reflections on dynamic prediction of Alzheimer's disease: advancements in modeling longitudinal outcomes and time-to-event data

Chen D, Zhang M, Han H, Wen Y, Yu H.

BMC Med Res Methodol. 2025 Jul 17;25(1):175. doi: 10.1186/s12874-025-02618-x.

The Impact of Awareness of Disease on Quality of Life of People With Alzheimer Disease

Nogueira MML, Oliveira F, Belfort T, Monteiro A, Gaigher J, Dourado MCN.

Alzheimer Dis Assoc Disord. 2025 Oct-Dec 01;39(4):256-262. doi: 10.1097/WAD.0000000000000682. Epub 2025 Nov 12.

Efficacy and Safety of Gantenerumab in Patients With Alzheimer Disease: A Systematic Review and Meta-analysis

Alla D, Malireddi A, Ramsundar R, Shah D, Alla SSM, Das A, Andanappa A, Emmanuel NW, Siddiqui S, Marepalli NR, Dugyala RR, Kolte R.

Clin Neuropharmacol. 2026 Jan-Feb 01;49(1):4-10. doi: 10.1097/WNF.0000000000000661. Epub 2025 Nov 24.

Network Analysis of Delusion Subtypes in Amyloid PET-Positive, Drug-Naïve Alzheimer's Disease Patients

Yang Y, Kwak YT.

Am J Geriatr Psychiatry. 2025 Nov;33(11):1207-1217. doi: 10.1016/j.jagp.2025.04.210. Epub 2025 Apr 22.

Changes in Daily Functioning in Association With Tau and Amyloid Among Unimpaired Older Adults With and Without Elevated Amyloid

Dubbelman MA, Liu A, Donohue MC, Langford O, Raman R, Rentz DM, Amariglio R, Sperling RA, Aisen PS, Marshall GA; as the A4 Study team.

Neurology. 2025 Jun 24;104(12):e213775. doi: 10.1212/WNL.0000000000213775. Epub 2025 May 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias